Yoram Bibring, Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 41,500 shares at $2.92 ($121K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |